Common Stock, Shares Authorized of MERRIMACK PHARMACEUTICALS INC from 31 Dec 2011 to 31 Mar 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
MERRIMACK PHARMACEUTICALS INC quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Dec 2011 to 31 Mar 2024.
  • MERRIMACK PHARMACEUTICALS INC Common Stock, Shares Authorized for the quarter ending 31 Mar 2024 was 30,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

MERRIMACK PHARMACEUTICALS INC Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 30,000,000 0 0% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 30,000,000 0 0% 31 Dec 2023 10-Q 15 May 2024 2024 Q1
Q3 2023 30,000,000 0 0% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 30,000,000 0 0% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 30,000,000 0 0% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 30,000,000 0 0% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 30,000,000 0 0% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 30,000,000 0 0% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 30,000,000 0 0% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 30,000,000 0 0% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 30,000,000 0 0% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 30,000,000 0 0% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 30,000,000 0 0% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 30,000,000 0 0% 31 Dec 2020 10-K 09 Mar 2022 2021 FY
Q3 2020 30,000,000 0 0% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 30,000,000 0 0% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 30,000,000 0 0% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 30,000,000 0 0% 31 Dec 2019 10-K 10 Mar 2021 2020 FY
Q3 2019 30,000,000 0 0% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 30,000,000 0 0% 30 Jun 2019 10-Q 17 Jul 2019 2019 Q2
Q1 2019 30,000,000 +10,000,000 +50% 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 30,000,000 +10,000,000 +50% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 30,000,000 +10,000,000 +50% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 30,000,000 -170,000,000 -85% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 20,000,000 -180,000,000 -90% 31 Mar 2018 10-Q 08 May 2018 2018 Q1
Q4 2017 20,000,000 0 0% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 20,000,000 -180,000,000 -90% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 200,000,000 0 0% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 200,000,000 0 0% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 20,000,000 0 0% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 200,000,000 0 0% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 200,000,000 0 0% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 200,000,000 0 0% 31 Mar 2016 10-Q 02 May 2016 2016 Q1
Q4 2015 20,000,000 -180,000,000 -90% 31 Dec 2015 8-K 15 Dec 2017
Q3 2015 200,000,000 0 0% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 200,000,000 0 0% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 200,000,000 0 0% 31 Mar 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 200,000,000 0 0% 31 Dec 2014 10-K 26 Feb 2016 2015 FY
Q3 2014 200,000,000 0 0% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 200,000,000 0 0% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 200,000,000 0 0% 31 Mar 2014 10-Q 06 May 2014 2014 Q1
Q4 2013 200,000,000 0 0% 31 Dec 2013 10-K 27 Feb 2015 2014 FY
Q3 2013 200,000,000 0 0% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 200,000,000 0 0% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 200,000,000 0 0% 31 Mar 2013 10-Q 13 May 2013 2013 Q1
Q4 2012 200,000,000 +61,500,000 +44% 31 Dec 2012 10-K 04 Mar 2014 2013 FY
Q3 2012 200,000,000 30 Sep 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 200,000,000 30 Jun 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 200,000,000 31 Mar 2012 10-K 27 Feb 2015 2014 FY
Q4 2011 138,500,000 31 Dec 2011 10-K 20 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.